Skip to main content
# Title Research Member Research Year
11 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia maureen raafat 2022
12 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Dr. Asmaa Mohamed Zahran Omar 2022
13 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Dr. Noha gaber sayed 2022
14 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Asmaa Mohamed Zahran Omar 2022
15 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Dr. Mohamed Galal Mostafa ELnaggar 2022
16 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Dalia Osama Mohamed Ahmed 2022
17 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Dr. Iman Hassan Ahmed Hamada 2021
18 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Eman Hosny Mohammed Ibrahim 2021
19 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Dr. Asmaa Mohamed Zahran Omar 2021
20 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Duaa Abdel-Samia Mohamed Ali 2021